CBD Stock 12 Month Analyst Forecast
Eps Overview
Growth Next 5yrs
N/A
Last Quarter
- $0.23
Past Year
- $0.03
Growth Past 5yrs
38.77%
Next Quarter
-
Estimate Next Year
$54.22
Consensus Rating
Loading...
Consensus Price Target
Highest Price Target
N/A
0% Upside
Mean Price Target
N/A
0% Upside
Lowest Price Target
N/A
0% Upside
Recent Analyst Ratings
Upgrades, Downgrades, New Coverage
Actual EPS vs Estimated EPS
CBD Earnings Per Share (EPS) History
According to financial reports, CBD (NYSE: CBD) reported an actual EPS of $-0.23 for the quarter ending on Feb 26, 2024, compared to an estimated $-0.10322, resulting in a 122.83% surprise. In the prior quarter (Jul 27, 2023), CBD recorded an actual EPS of $0.19 with a 0.00% surprise. See CBD's full earnings history.
Earnings History
EPS Surprise Factor Analysis
CBD has experienced notable EPS surprises, with the latest quarter ending Feb 26, 2024 showing a 122.83% beat. Previously, the quarter ending Jul 27, 2023 recorded a 0.00% beat. An EPS surprise factor indicates how much actual earnings deviate from analyst forecasts.
| Report Date | Actual | Forecast | Surprise Factor |
|---|---|---|---|
| Feb 26, 2024 | -0.23 | -0.10322 | +122.83% |
| Jul 27, 2023 | 0.19 | 0.19 | 0 |
| May 04, 2023 | -0.23 | -0.11 | +109.09% |
| Mar 02, 2023 | -1.97439 | 0.01 | -19,843.90% |
| Nov 03, 2022 | -0.21 | -0.18 | +16.67% |
| Jul 27, 2022 | -0.11 | -0.00678 | +1,522.42% |
Frequently Asked Questions
Is CBD stock getting favorable reviews from Wall Street analysts?
Brokerage firms have given CBD stock an average recommendation of
N/A. 0 analysts have given their ratings
to CBD out of which
0 analysts have given strong buy call,
0 analysts have given buy call,
0 analysts rate it hold,
0 analysts advocate strong sell call, and
0 analysts has given sell rating. The average target price of
- gives the stock implied downside
of roughly 0% over the next year or so.
What have analysts suggested for CBD highest price target?
Analysts suggest CBD's stock price would rise to a high of -.
What is the lowest price target analysts expect for CBD over the next year?
Within the next 12 months, analysts predict the CBD stock price could move to -.
What is the average target price for CBD?
CBD stock has an average analyst estimate of -.
At its current price, how far is CBD from its average target price?
CBD shares are currently trading 0% below this price target.
What were CBD’s actual earnings per share for the recent quarter?
Its quarterly earnings per share (EPS) came in at - $0.23 versus consensus estimates of - $0.10, and below the comparable year-ago quarter’s EPS of - $0.21.
What are the current estimates for quarterly and annual earnings per share?
CBD's forecasts by analysts estimating quarterly EPS at - and $54.22 for the whole year.
What has CBD's growth been in the past five years and what is expected in the next five years?
The analysts have projected N/A EPS growth for CBD in the next five years, compared to growth rates of 38.77% in the past five years.